Artificial intelligence is breaking into the precision medicine by assisting doctors to make complicated decisions faster and more efficiently. The Englander Institute for Precision Medicine (EIPM) has developed AI to help doctors find the right genes that lead to diseases. There is a great amount of research and drugs developed relating to cancer. In detail, there are more than 800 medicines and vaccines designed for cancer. This negatively affects the doctors, because there are too many options to choose from, making it more difficult to choose the right drugs for the patients.

Researchers with AI can learn both from the efficacy of a small number of combinations and the mechanisms of biology, “we can narrow down which drugs may be good candidates for testing because there’s no way to experimentally test all of them,” said Dr. Elemento the Director of the Englander Institute for Precision Medicine, “AI can point you to a small number of combinations highly likely to be effective, without the need to brute force test thousands of combinations in the lab,” Dr. Elemento added. In addition, the EIPM team in conjunction with Microsoft developer created the PMKB Bot, a chatbot that supports both text and voice interactions with the Precision Medicine Knowledgebase (PMKB) for clinical cancer variants and interpretations.

More about the Projects, Featured Publications, Press coverage and collaborators for the AI projects of the Englander Institute for Precision Medicine:  BANDIT ,  PrOCTOR, and  PMKB Bot.